ABSTRACT:
Teneligliptin is a BCS class-II anti-diabetic drug having poor solubility and lesser bioavailability. This study aimed to prepare and evaluate the proniosomal powders of Teneligliptin and compress them into tablets to improve the solubility and enhance bioavailability. Free-flowing proniosomal powders of Teneligliptin were prepared by using the slurry method, and maltodextrin was used as a carrier. A total of six Teneligliptin Proniosomal formulations were prepared with various concentrations of cholesterol, span, tween, and soya lecithin. All the prepared formulations were evaluated for, FT-IR analysis, % Entrapment efficiency, In-vitro drug release studies, Vesicle size analysis, and Scanning electron microscopy. Among all the formulations, proniosomal formulation 2(PF2) was found to exhibit the best results for all the evaluation tests, and In vitro drug release was found to be 99.56% at the end of the 24th hour. The proniosomal powder was evaluated for Micromertic properties. The proniosomal powder of the PF2 was successively compressed into a tablet by using the direct compression method. The compressed tablets were characterized for weight variability, friability, hardness, drug content uniformity, and dissolution properties. The dissolution data obtained for the proniosomal teneligliptin tablet were fitted with various release kinetic equations, and the release followed zero-order kinetics.The Proniosomal tablets are a promising approach for Teneligtiptin to overcome the solubility and to increase the drug bioavailability. Overall, the importance of proniosomal tablets is found in their ability to optimize drug delivery, improve patient outcomes, and enhance the overall effectiveness of therapeutic agents.
Cite this article:
Jeevan Nithish S, C. Rubina Reichal. Formulation and Characterization of Proniosomal Teneligliptin Tablets. Research Journal of Pharmacy and Technology. 2026;19(4):1751-6. doi: 10.52711/0974-360X.2026.00251
Cite(Electronic):
Jeevan Nithish S, C. Rubina Reichal. Formulation and Characterization of Proniosomal Teneligliptin Tablets. Research Journal of Pharmacy and Technology. 2026;19(4):1751-6. doi: 10.52711/0974-360X.2026.00251 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-4-40
REFERENCES:
1. Raju BP, Shirolkar SV. Formulation and Evaluation of Teneligliptine Pellet. International Journal of Drug Delivery Technology. 2019; 9(1): 51-7.
2. Aparna A, Reichal CR, Shobana M. Formulation and characterization of gastroretentive drug delivery system of teneligliptin. Research Journal of Pharmacy and Technology. 2023;16 (11): 5027-33.
3. Sreekala. MG, C. Rubina Reichal, Manju. S. Formulation and Evaluation of Teneligliptin Nanosuspension. Research Journal of Pharmacy and Technology. 2024; 17(1): 96-2. doi: 10.52711/0974-360X.2024.00015
4. Sharma SK, Panneerselvam A, Singh KP, Parmar G, Gadge P, Swami OC. Teneligliptin in management of type 2 diabetes mellitus. Diabetes, metabolic syndrome and obesity: targets and therapy. 2016; 16: 251-60.
5. E.A. Mazyed, S. Zakaria, Enhancement of dissolution characteristics of clopidogrel bisulphate by proniosomes Int. J. App. Pharm. 2019; 11: 77-85.
6. Walve et al., Proniosomes: A surrogate carrier for improved transdermal drug delivery system,Int. J. Res. Ayurveda Pharm. 2001; 2: 743-750.
7. Baghel S, Cathcart H, O’reilly NJ. Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci. 2016; 105(9): 2527–2544.
8. Sharma SK, Panneerselvam A, Singh KP, Parmar G, Gadge P, Swami OC. Teneligliptin in management of type 2 diabetes mellitus. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2016; 16: 251-60.
9. Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS Pharmscitech. 2010; 11: 1119-27.
10. Hua S. Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery. International Journal of Nanomedicine. 2014; 30: 735-44.
11. Shehata TM, Abdallah MH, Ibrahim MM. Proniosomal oral tablets for controlled delivery and enhanced pharmacokinetic properties of acemetacin. AAPS Pharm Sci Tech. 2015; 16: 375–383.
12. Sachan AK, Kumar S, Dwivedi T. A Review Article on Proniosome: As A Drug Carrier. Asian Journal of Pharmaceutical Research and Development. 2021; 9(4): 128-31.
13. Sabareesh M, Yanadaiah JP, Sekhar KC. A novel vesicular approach for transdermal administration of enalapril maleate loaded nanoproniosomal gel: Formulation, ex vivo evaluation and in vivo antihypertensive study. International Journal of Applied Pharmaceutics. 2020; 12 (5): 190-202.
14. Alshora D, Ibrahim M, Alanazi N, Alowyid M, Alnakhli ZA, Alshiban NM, Maodaa S, Alyami NM, Alotaibi I. Formulation of Glibenclamide proniosomes for oral administration: Pharmaceutical and Pharmacodynamics Evaluation. Saudi Pharmaceutical Journal. 2023; 31(12): 101830.
15. Mansi Barot, Anuradha P. Prajapati, Neha Vadgama, Sachin B. Narkhede, Shailesh Luhar.Formulation Development and Evaluation of Proniosomal Gel containing Crisaborole. Research Journal of Pharmacy and Technology. 2025; 18(5): 2261-8. doi: 10.52711/0974-360X.2025.00324.
16. 16.Kondawar MS, Kamble KG, Malusare MK, Waghmare JJ, Shah ND. Proniosome based drug delivery system for clotrimazole. Research Journal of Pharmacy and Technology. 2011; 4(8): 1284-7.
17. Lathiyare KB, Jain V. Development and characterization of karanj oil based proniosomal gel for topical delivery. Research Journal of Pharmacy and Technology. 2014; 7(9): 959-62.
18. Kishore Kamere, S.V Gopalakrishna, G.V. Subbareddy. Optimization of Repaglinide Controlled Release Floating Tablet. Research J. Pharm. and Tech. 2021; 14(1): 109-114. doi: 10.5958/0974-360X.2021.00020.2
19. S Gopalakrishnan, A Chenthilnathan. Formulation and In Vitro evaluation of Aceclofenac oral floating tablets. Research J. Pharm. and Tech. 2011; 4(4): 642-645.
20. Varma MM, Suneetha S, Raju DB. Design and Evaluation of Floating Drug Delivery System of Furosemide. Research J. Pharm. and Tech. 2010; 3(2): 452-454.
21. Hyma Ponnaganti, Abbulu. K. Enhanced Dissolution of Repaglinide: SMEDDS Formulation and In-vitro Evaluation. Research J. Pharm. and Tech. 2014; 7(11): 1246-1252.
22. 22.Vidhi Patel, Princy Patel, Pravinkumar M. Patel, Snehal Patel, Jigar V Patel. Synthesized Nanostructured Dendrimer’s Proposal of a Practical Strategy to Improve the Solubility of Domperidone. Research Journal of Pharmacy and Technology. 2024; 17(11): 5386-2. doi: 10.52711/0974-360X.2024.00823.
23. 23. Pasam Jyothirmayi, Arigela Bharathi, D Rama Sekhara Reddy.Design, Formulation, Evaluation and Statistical Optimization of Coated Floating Pulsatile Tablets for Modified Chronopharmacotherapy of Rheumatoid Arthritis. Research Journal of Pharmacy and Technology. 2024; 17(11): 5491-8. doi: 10.52711/0974-360X.2024.00840
24. 24.Gautami Deepak Khalap, Prasad Desai, Suwarna Suresh Bobde.Design and Statistical Optimization of Gastroretentive Drug Delivery System of Domperidone Maleate. Research Journal of Pharmacy and Technology. 2024; 17(11): 5525-0. doi: 10.52711/0974-360X.2024.00844
25. 25.Prasanthi Teella, Sri Nataraj Kalakonda, Rajeswari Saripilli.Design and Characterization of bimodal Release Formulation of Valsartan and Metformin hydrochloride. Research Journal of Pharmacy and Technology. 2024; 17(11): 5575-3. doi: 10.52711/0974-360X.2024.00851
26. Shilpaja Chella, Saravanakumar Kasimedu, Nagaveni Pommala, Ashok Thulluru, Mallikarjuna Gandla, Prudhvi Raj Vadamala.Chitosan Nanoparticles Enhance Permeability of Rizatriptan in Mucoadhesive Buccal Films: A Promising approach for Improved Drug Delivery. Research Journal of Pharmacy and Technology. 2025; 18(3): 1308-6. doi: 10.52711/0974-360X.2025.00
27. Ali Bustani, Yaser Bitar, Wassim Abdelwahed.Formulation and Evaluation of Orally Disintegrating Tablets of Tadalafil and Dapoxetine HCl prepared by Direct Compression and Freeze-Drying Techniques with Taste Masking of Dapoxetine HCl. Research Journal of Pharmacy and Technology. 2025; 18(3): 1336-5. doi: 10.52711/0974-360X.2025.00194
28. Teaima MH, Yasser M, El-Nabarawi MA, Helal DA.Proniosomal telmisartan tablets: formulation, in vitro evaluation and in vivo comparative pharmacokinetic study in rabbits. Drug design, Development and Therapy. 2020; 31: 1319-31.
29. Sahoo RK, Biswas N, Guha A, Sahoo N, Kuotsu K. Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide–maltodextrin complex. Acta Pharm Sin B. 2014; 4: 4(5): 408–416.
30. Kim DH, Ohnishi ST, Ikemoto N. Kinetic studies of calcium release from sarcoplasmic reticulum in vitro. Journal of Biological Chemistry. 1983; 25: 258 (16): 9662-8.
31. 31.Pawan Singh, Prevesh Kumar, Neelkant Prasad. Formulation and Evaluation of Aspirin Tablets by Using Different Lubricants in Combination for better Kinetic Drug Release Study by PCP. Research J. Pharm. and Tech. 2017; 10(9): 2934-2938. doi: 10.5958/0974-360X.2017.00519.4